S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Total Liabilities
kr12.1m
CAGR 3-Years
47%
CAGR 5-Years
58%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Total Liabilities
kr276.9B
CAGR 3-Years
37%
CAGR 5-Years
31%
CAGR 10-Years
24%
H Lundbeck A/S
CSE:HLUN A
Total Liabilities
kr15.4B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Total Liabilities
kr2.3B
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Total Liabilities?
Total Liabilities
12.1m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Total Liabilities amounts to 12.1m DKK.

What is Stenocare A/S's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
58%

Over the last year, the Total Liabilities growth was -22%. The average annual Total Liabilities growth rates for Stenocare A/S have been 47% over the past three years , 58% over the past five years .

Back to Top